Movement Alert|Monster Beverage Intraday Decline 3.45%, Q2 Earnings Beat Overshadowed by H2 High-Base Concerns

Market Focus08-07 22:35

On August 7, Monster Beverage fell 3.45% in regular trading, trading around $90.65/share with turnover of $118 million. The decline came despite a Q2 earnings beat released the prior evening.

Monster Beverage reported Q2 adjusted EPS of $0.60, exceeding the consensus estimate of $0.58, while revenue of $2.54 billion grew 20.4% year-over-year and topped the $2.43 billion expectation. Despite the double beat, the stock sold off as investors focused on forward headwinds. UBS had previously highlighted that the company faces tougher year-over-year comparisons in H2, a slower new product cadence, and a stretched valuation that could make further share price appreciation difficult. Morgan Stanley raised its target price to $110 from $103 post-earnings while maintaining an Overweight rating, but market sentiment remained dominated by concerns over decelerating medium-term growth momentum. Additionally, a coalition including Monster Beverage is lobbying regulators for a one-year extension on labeling changes, citing millions of units in existing inventory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment